To test the effectiveness of a step-by step, evidence-based guide, the 4 Pillars Practice Transformation Program, to increase adult pneumococcal vaccination. (rural, urban, suburban), and type (family medicine, internal medicine), randomized to receive the intervention in Year 1 (n = 13) or Year 2 (n = 12). PARTICIPANTS: Individuals aged 65 and older at baseline (N = 18,107; mean age 74.2; 60.7% female, 16.5% non-white, 15.7% Hispanic). INTERVENTION: The 4 Pillars Program, provider education, and one-on-one coaching of practice-based immunization champions. Outcome measures were 23-valent pneumococcal polysaccharide vaccine (PPSV) and pneumococcal conjugate vaccine (PCV) vaccination rates and percentage point (PP) changes in vaccination rates. RESULTS: In the Year 1 RCCT, PPSV vaccination rates increased significantly in all intervention and control groups, with average increases ranging from 6.5 to 8.7 PP (P <
A dult immunizations have been garnering increased attention as an important area for quality improvement for several reasons. First, Healthy People 2020 goals for vaccines given to adults have not been met. In 2013, pneumococcal vaccination uptake in the United States was 21.2% in individuals aged 19-64 with high-risk conditions, 1 compared with a goal of 60%, 2 and 59.7% in individuals aged 65 and older, 1 compared with a goal of 90%. 2 Second, the National Quality Strategy, established under the Affordable Care Act, has set a long-term goal of promoting "healthy living and well-being through receipt of effective clinical preventive services across the lifespan in clinic and community settings." 3 The Centers for Medicare and Medicaid Services (CMS) has also made reporting of influenza and pneumococcal vaccination one requirement for providers to avoid negative payment adjustments. 4 Adult immunizations are viewed as an integral part of quality care.
Provider barriers to adult vaccination include economic barriers arising from Medicare coverage that varies according to vaccine, inconvenient vaccine storage in some medical offices, urgent and chronic medical conditions competing with time for prevention efforts, uncertainty about the individual's vaccination status, missed immunization opportunities, and lack of patient and provider reminders. [5] [6] [7] [8] [9] [10] Patient-related barriers include not knowing that a vaccine was recommended, not believing that the clinician recommended the vaccine, and fear of vaccine side effects. 7, [11] [12] [13] Facilitators of vaccination include standing order programs, prompts from the electronic medical record, use of teamwork, and longer time with the physician. 14 Based on a comprehensive literature review, the Community Preventive Services Task Force found that improving vaccination uptake requires behavior changes at the system, provider, support staff, and patient levels. 15 Sustainable change requires a coordinated, multipronged, adaptable approach; hence, the need for a practice improvement program that can support change in diverse practice cultures is evident. The 4 Pillars Practice Transformation Program (also called the 4 Pillars Immunization Toolkit) is the product of years of health services research on barriers to and facilitators of adult immunizations from the provider and patient perspectives, 11, 16 national and local surveys, 5, 6, 17 and pilot studies on a toolkit to increase use of standing orders for adult vaccines. 18 This was a 2-year study of 25 primary care practices to test the effectiveness of the 4 Pillars Program for increasing uptake of pneumococcal polysaccharide vaccine (PPSV) and, in Year 2, the newly recommended 13-valent pneumococcal conjugate vaccine (PCV) in adults aged 65 and older. The purpose of this study was to report the effect of the intervention on pneumococcal vaccination rates, percentage point (PP) differences in vaccination rates, and likelihood of pneumococcal vaccination. The data are presented in two ways. The randomized controlled cluster trial (RCCT) analysis compared changes in vaccine uptake in the intervention and control groups at the end of Year 1. In Year 2, controls were crossed over into active intervention, and the Year 1 intervention groups became maintenance groups. Year 2 data were analyzed using a pre-post design in which changes in vaccine uptake were measured from the end of Year 1 to the end of the Year 2 intervention. 
METHODS

Sample Size and Sites
Optimal Design software version 1.77 (University of Michigan, Ann Arbor, MI) was used to calculate sample size for a RCCT seeking a 10% to 15% absolute increase in vaccination rate and a minimum practice size of 100 patients. A sample size of 20 clusters or sites (10 intervention and 10 control practices) was determined to be necessary to achieve 80% power with an alpha of .05. Eligible primary care family medicine and internal medicine practices from a practice-based research network in Pittsburgh (FM Pittnet), a clinical network in southwestern Pennsylvania (Community Medicine, Inc.), and a practicebased research network of safety net practices in Houston (Southern Primary-care Urban Research Network (SPURNet)) were solicited for participation. When 25 sites agreed to participate, solicitation ceased. All sites used a common electronic medical record (EMR; EpicCare, Epic, Verona, WI) within their respective health systems.
Cluster Randomization
Cluster randomization allocates clinical practices rather than individuals to intervention arms. 19 Some practices had more than one site; each site was considered a cluster. Eligibility requirements included having at least 100 patients aged 18 and older, preliminary baseline vaccination rates for at least one adult vaccine (influenza; pneumococcal; combined tetanus, diphtheria, pertussis) of less than 50%, and a willingness to make office changes to increase vaccination rates. Participating practices were stratified first according to metropolitan area (Pittsburgh, Houston), location (urban, suburban, rural), and discipline (internal, family medicine). The practices were then randomized into the Year 1 intervention or Year 2 intervention within strata (Figure 1 ). Year 2 intervention sites (controls) were informed that their intervention would take place during Year 2 of the study and were not contacted again until the next year.
Pillars Program
The 4 Pillars Program is founded on four evidencebased 15, 20 strategies: Pillar 1-convenient vaccination services; Pillar 2-communication with patients about the importance of immunization and the availability of vaccines; Pillar 3-enhanced office systems to facilitate immunization; Pillar 4-motivation through an office immunization champion (IC). Table S1 describes some of the strategies contained in the 4 Pillars Program. The 4 Pillars Program includes background on the importance of protecting people against vaccine-preventable diseases, barriers to increasing vaccination from provider and patient perspectives, and strategies to eliminate those barriers. Practices were expected to implement strategies from each of the four pillars.
In Year 1, the 4 Pillars Program was offered in a printed and bound document supplemented by a webbased practice transformation dashboard. The dashboard was developed from previous work that established an empirically based implementation framework that includes systematic uptake, establishment, and maintenance of research findings into routine practice. 21 The core components include staff selection and training on the specific evidence-based practices, expert consultation and coaching of staff and administration, program evaluation to assess and provide feedback, facilitative administrative supports to ensure that data are used to focus and inform decisionmaking, and systems interventions.
Once the practice was registered, any staff member could log into the dashboard. The IC was responsible for registering the practice and its staff members and identifying strategies that the practice would implement. The 4 Pillars Program provided step-by-step guidance for implementing the strategies, and the dashboard showed the practices' progress through the change process. Practices could monitor their progress on graphs that reported numbers of vaccines given, every other week. In Year 2, the 4 Pillars Program was fully digitized to a website (4pillarstoolkit.pitt.edu) that incorporated all of the paper-based background information and the dashboard capabilities.
Intervention
The intervention was designed using diffusion of innovations theory 22 and included the 4 Pillars Program and dashboard, provider education, and one-on-one coaching of the IC for each practice. One of two investigators (AEB, MPN) visited each intervention site to introduce the study and the 4 Pillars Program and to work with staff to develop practice-specific ideas for implementing strategies. The IC was responsible in Year 1 for updating the practice transformation dashboard as intervention strategies were employed and in Year 2 for using the 4 Pillars website to guide strategy implementation and record progress in the dashboard, assisted by the research liaison as needed. Other tasks for the IC included participating in the telephone call every other week with a research liaison for coaching, ensuring that chosen strategies were being implemented, and working to maintain motivation of the staff.
The 4 Pillars Program was updated with new pneumococcal vaccination recommendations during Year 2, at the end of September 2014, within a few days of their publication, and each practice's leadership team was directly notified by e-mail of the changes to the pneumococcal recommendations. In November 2014, additional information was sent to the Pittsburgh practices about local insurance coverage for PCV vaccines. Information on CMS coverage for PCV was sent to all practices in early January 2015.
Data Collection
Deidentified information on demographic characteristics (date of birth, sex, race or ethnicity, health insurance coverage), office visits (dates), and vaccinations (vaccines given and dates) were derived from EMR data extractions that the UPMC Center for Assistance in Research Using 
Statistical Analyses
Descriptive analyses were performed for demographic characteristics (age, sex, race, ethnicity). Age was used as a continuous variable. Health insurance was not included in the regression analyses because all insurances would have covered pneumococcal vaccine in individuals aged 65 and older. Race and ethnicity were recorded differently in each city. In Pittsburgh, with few Hispanic patients, ethnicity was rarely recorded, so participants were grouped according to race into white and nonwhite with blacks and Hispanics assigned to the nonwhite group, and only race data are presented and used in the analysis. In Houston, with few non-Hispanic patients, race was rarely recorded, so only ethnicity (Hispanic and non-Hispanic) is presented and used in the analysis. Because of these differences in patient populations, size, and structure of the practices between Houston and Pittsburgh, they were grouped separately for analysis. . Proportions were reported for categorical variables, and means and standard deviations were reported for continuous variables. The primary outcome measures were cumulative PPSV and PCV vaccination rates reported at baseline, Year 1, and Year 2. Chi-square tests were performed to test for differences in cumulative vaccination rates at different time points.
Year 1 RCCT Analyses
To determine which factors were related to PPSV vaccination while accounting for the clustered nature of the data, Cox proportional hazards models with the robust sandwich estimate were fitted, taking account of heterogeneity in demographic characteristics (including age, sex, and race or ethnicity). Because of the lack of variability in the number of strategies that practices used and the correlation between strategies and intervention group, only intervention group was included in the models.
Year 2 Pre-Post Analyses
At the end of Year 1, practices were offered the opportunity to continue active intervention during Year 2. Four practices opted to do so. At the same time, the Year 1 control sites began the intervention. For the pre-post analyses, the four practices in Pittsburgh that continued the intervention in Year 2 were combined with the Year 1 control sites and were referred to as the active intervention group. The remaining six practices that did not actively participate in Year 2 were referred to as the maintenance group. In Houston, the Year 1 intervention sites were referred to as the maintenance group, and the Year 1 control sites that received the intervention in Year 2 were referred to as the active intervention group. Cox proportional hazards models with the robust sandwich estimates were again fitted, taking into account heterogeneity in demographic characteristics (including age, sex, race or ethnicity) to determine which factors were related to PPSV and PCV uptake. Statistical significance of two-sided tests was set at a type I error (alpha) equal to .05. All analytical procedures were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC).
RESULTS
Twenty-four sites completed the intervention; demographic and other characteristics of patients are shown in Table 1 . The large differences between practices in Houston and Pittsburgh supported the separate analyses of sites according to city. Houston sites were larger practices with higher reported proportions of Hispanic patients, female patients, and noncommercially insured patients than the Pittsburgh sites.
Year 1 RCCT Study
Cumulative PPSV vaccination rates for all patients at baseline and Year 1 are shown in Table 2 according to site and intervention group. Individual practice baseline rates for PPSV ranged from a high of 80.9% to a low of 31.0%, with average baseline rates of 71.4% for the intervention group in Pittsburgh and 67.7% in Houston.
At the end of the intervention year, PPSV rates had increased significantly in the intervention and control groups in both cities. Increases ranged from 6.5 to 8.7 PP (P < .001 by chi-square test for baseline to Year 1 rates). The differences in PP changes between the intervention and control groups were significant for the Houston sites (P < .001), but not for the Pittsburgh sites (P = .84).
Regression analyses that accounted for the clustered nature of the data, as well as race or ethnicity, age, and sex were conducted to determine the effect of the intervention on vaccination rates in the RCCT (Table 3 ). The likelihood of PPSV vaccination in Year 1 was not related to the intervention but was significantly related to younger age (P < .001) in the Pittsburgh sites. Similarly, in the Houston sites, younger age and non-Hispanic ethnicity, but not the intervention, were related to a greater likelihood of PPSV vaccination.
Year 2 Pre-Post Study
At the end of the pre-post study comparing the Year 2 active intervention sites and the maintenance sites, individual site PPSV rates ranged from a low of 43.4% to a high of 94.7% (data not shown). PP differences from Year 1 to Year 2 in the maintenance and active intervention sites are shown in Table 4 . PPSV vaccination rates increased significantly in both cities in the active intervention and maintenance groups from Year 1 to Year 2 (P < .001). By the end of Year 2, 79% of practices (19/24) had PPSV rates at or above 70%, and 58% of practices (14/24) had PPSV rates at or above 80% (data not shown).
Percentage point differences in PCV vaccination rates for individual practices at the end of Year 2 are also shown in Table 4 . Overall, the increase in PCV rates in active intervention sites was significantly greater than in the maintenance sites (P < .001 Pittsburgh sites, P = .008 Houston sites). Figure 2 shows PPSV and PCV vaccination rates for the active intervention and maintenance groups from baseline to the end of follow-up.
The likelihood of receipt of PPSV at the end of the pre-post study in Pittsburgh was significantly greater for the active intervention group, for men, and for younger patients than for the maintenance group, women, and older patients (P < .05) ( Table 5 ). In the Houston sites, there was no effect of the intervention on likelihood of PPSV receipt, but men and non-Hispanic patients were more likely to receive PPSV than women and Hispanic patients (P < .001).
The effect of the intervention on the recently introduced PCV was marked; those in the active intervention group were 14.7 times as likely to receive PCV as those in the maintenance group. Age was related to likelihood of PCV vaccination, but in this case it was the older patients who were more likely to receive the vaccine. In the Houston sites, there was no effect of the intervention on the likelihood of PCV receipt, although non-Hispanic patients were twice as likely to receive PCV as Hispanic patients (P = .02) and older patients were slightly more likely to receive PCV (P < .001).
DISCUSSION
National coverage for PPSV for adults aged 65 and older was 59.7% in 2013, a level similar to recent years. 1, 23 In this study, many but not all sites reported baseline rates above that level, which is probably because study participants had access to primary care. Over the course of the RCCT, PPSV uptake increased significantly in the intervention and control groups and increased measurably in most individual practices. During Year 2, the active intervention group increased average PPSV rates by 4.6-5.2 PPs, and the maintenance groups increased their average PPSV rates by 2.4-6.5 PPs. These increases are considerably higher than recent secular trends. In previous research, pediatric practices seemed to reach a plateau in influenza vaccination rates at approximately 58%. 24 This study shows that, using a directed effort, even practices with relatively high baseline vaccination rates can increase the proportion of their adult patients who receive PPSV. Such increases will help practices achieve quality improvement goals that CMS 4 and the National Quality Strategy 3 have set forth. In the RCCT and the pre-post study, younger age was associated with greater likelihood of PPSV vaccination, suggesting that practices targeted patients for PPSV vaccination as soon as they became 65; this may be a successful strategy. There is no obvious explanation for why women were less likely to be vaccinated in the pre-post study or why non-Hispanic patients were more likely to receive PPSV in the RCCT but not in the pre-post study. These findings suggest that special efforts to market adult vaccines to population subgroups may be required.
According to reports from the research liaisons, adoption and implementation, which are components of the Reach Effectiveness Adoption Implementation Maintenance evaluation framework, 22, 25 varied according to site, which probably reflects the unique practice cultures of the sites. Anecdotally, usability of the dashboard was a reported problem in Year 1 that was improved for Year 2. One practice served a religious sect that is hesitant about vaccination, another practice that served a large immigrant community closed one of its two offices during Year 2, and another site was late in adoption of the intervention in Year 2.
In December 2011, the Food and Drug Administration licensed PCV for use in adults aged 50 and older, 26 and the following June, the Advisory Committee on Immunization Practices recommended its use for adults aged 19 and older with certain high-risk and immunocompromising conditions. 27 In September 2014, CDC recommended that PCV be administered to all adults aged 65 and older in series with PPSV. 28 Hence, PCV was available and recommended for use in high-risk individuals but was not universally recommended for all adults at the time that the study began in 2013, and there are no national comparison data for PCV uptake during the time frame of the study. The current study found significantly greater likelihood of PCV vaccination in the active intervention groups than in the maintenance groups, indicating a significant effect of the intervention on vaccination rates.
In late 2014, the participating practices reported some confusion as to whether health insurance plans would cover administration of both vaccines, and this may have delayed their uptake. This experience speaks to the need for easy-to-use resources such as the 4 Pillars Practice Transformation Program to help physicians and clinical staffs understand the implications of changing vaccine recommendations and reimbursement policies. Practices have been shown to improve implementation of interventions when they are well supported through a facilitator such as an IC 29, 30 and specifically to increase pneumococcal vaccination using clinician education and financial incentives. 
STRENGTHS AND LIMITATIONS
The strengths of this study are its randomized design, the large number and diversity of patients, diverse practice settings including safety net clinics, randomized design, and two intervention years of vaccination reporting. Limitations are that, during the Year 1 intervention, delivery of the EMR data was delayed, preventing the research team from providing feedback to the sites in both cities about their progress. The CDC's change in recommendations regarding PCV late in Year 2 with the related confusion about Medicare coverage interfered with implementation. Given the increase in immunization rates in the control arm in Year 1, either intervention transference between study arms occurred in sites within the same network (a Hawthorne effect), or secular trends occurred; nationally, PPSV rates have been relatively flat, arguing against national secular trends. 1 
CONCLUSIONS
In a RCCT, the intervention and control groups increased PPSV vaccination in adults aged 65 and older. In a prepost study, small to medium-sized private primary care practices using the 4 Pillars Practice Transformation Program improved PPSV and PCV uptake significantly more than similar practices that were in the maintenance phase of the study. In large safety net practices, the intervention did not result in significant improvements in PPSV or PCV uptake. The 4 Pillars Program may need modifications to address the needs of this type of practice. This investigation was supported by Grant U01 IP000662 from the CDC. The views expressed herein are those of those authors and not those of the CDC. The project described was also supported by the National Institutes of Health through Grants UL1 RR024153 and UL1TR000005.
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